Applied DNA Sciences subsidiary Applied DNA Clinical Laboratories has won contract for Covid-19 surveillance testing under its testing-as-a-service offering. This offering is expected to generate a total annualised revenue of over $1m.
Thermo Fisher Scientific has announced the launch of two new SARS-CoV-2 antibody tests, the Thermo Scientific OmniPATH Covid-19 Total Antibody ELISA test and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. OmniPATH Covid-19 Total Antibody ELISA test has received the Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA). The EUA for the EliA SARS-CoV-2-Sp1 IgG test is under review by the FDA. Currently, the test is available under the FDA’s Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised).
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
BioGX has received EUA from the FDA for an extraction-free, direct sample addition RT-PCR test to detect SARS-CoV-2 viral RNA in patients. The Xfree Covid-19 Direct RT-PCR test is a complete test in a single vial, lyophilized in BioGX Sample-Ready format.
Abbott has received EUA from the FDA for its AdviseDx SARS-CoV-2 IgM lab-based serology test. The test is designed to be used on the ARCHITECT and Alinity platforms. Abbott has received EUA for seven Covid-19 tests since the start of the pandemic.
